Abstract
Autophagy is a relevant cellular defense mechanism that directly eliminates intracellular pathogens and has a crucial role for innate and adaptive immune responses. Some viruses have developed tools to counteract this cellular response. A179L, the viral Bcl2 homolog of African swine fever virus, interacts with proapoptotic Bcl2 family proteins to inhibit apoptosis. Here we report that this gene manipulates autophagy by interacting with Beclin 1 through its BH3 homology domain. At subcellular level, A179L colocalized with Beclin 1 at mitochondria and the endoplasmic reticulum. Virus infection inhibited autophagosome formation in cells; however, when autophagy was induced prior to or at the time of infection the number of infected cells was severely decreased.
Keywords: African swine fever virus, ASFV, autophagy, Beclin 1, BH3-only proteins, ER stress, viral Bcl2, viral Bcl2 homolog, autophagosomes, stress, starvation, homeostasis, hemorrhagic disease, pathogenesis, lymphoid hyperplasia.
Current Molecular Medicine
Title:A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein
Volume: 13 Issue: 2
Author(s): B. Hernaez, M. Cabezas, R. Munoz-Moreno, I. Galindo, M. A. Cuesta-Geijo and C. Alonso
Affiliation:
Keywords: African swine fever virus, ASFV, autophagy, Beclin 1, BH3-only proteins, ER stress, viral Bcl2, viral Bcl2 homolog, autophagosomes, stress, starvation, homeostasis, hemorrhagic disease, pathogenesis, lymphoid hyperplasia.
Abstract: Autophagy is a relevant cellular defense mechanism that directly eliminates intracellular pathogens and has a crucial role for innate and adaptive immune responses. Some viruses have developed tools to counteract this cellular response. A179L, the viral Bcl2 homolog of African swine fever virus, interacts with proapoptotic Bcl2 family proteins to inhibit apoptosis. Here we report that this gene manipulates autophagy by interacting with Beclin 1 through its BH3 homology domain. At subcellular level, A179L colocalized with Beclin 1 at mitochondria and the endoplasmic reticulum. Virus infection inhibited autophagosome formation in cells; however, when autophagy was induced prior to or at the time of infection the number of infected cells was severely decreased.
Export Options
About this article
Cite this article as:
Hernaez B., Cabezas M., Munoz-Moreno R., Galindo I., Cuesta-Geijo A. M. and Alonso C., A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein, Current Molecular Medicine 2013; 13 (2) . https://dx.doi.org/10.2174/15665240113130200007
DOI https://dx.doi.org/10.2174/15665240113130200007 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PLK1 Inhibition Radiosensitizes Breast Cancer Cells, but Shows Low Efficacy as Monotherapy or in Combination with other Cytotoxic Drugs
Anti-Cancer Agents in Medicinal Chemistry Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies
Current Pharmaceutical Design Phytochemicals to Prevent Inflammation and Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Complications of Muscle Hematomas in Hemophilia
Cardiovascular & Hematological Disorders-Drug Targets Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents
Recent Patents on Drug Delivery & Formulation Targeting the Immune System in Cancer
Current Pharmaceutical Biotechnology FTD and ALS: A Tale of Two Diseases
Current Alzheimer Research Studies of NVP-BEZ235 in Melanoma
Current Cancer Drug Targets Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Prevalence of Dilated Cardiomyopathy in HIV-Infected African Patients Not Receiving HAART: A Multicenter, Observational, Prospective, Cohort Study in Rwanda
Current HIV Research Single Nucleotide Polymorphism Analysis in HIV and Kaposi's Sarcoma Disease by Microarray Technique
Current HIV Research Insights into Targeting NEMO for Pharmacological Regulation
Current Drug Targets Molecular Targeted Therapy of Gastrointestinal Stromal Tumors
Current Cancer Drug Targets FDG-PET in Tuberculosis
Current Molecular Imaging (Discontinued) Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential
Current Drug Targets Targeting Hypoxia for Sensitization of Tumors to Radio- and Chemotherapy
Current Cancer Drug Targets Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology
Current Chemical Biology Baculovirus as Vaccine Vectors
Current Gene Therapy Carbonic Anhydrase Inhibitors and the Management of Cancer
Current Topics in Medicinal Chemistry Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line
Anti-Cancer Agents in Medicinal Chemistry